Cefepime Mylan

Šalis: Naujoji Zelandija

kalba: anglų

Šaltinis: Medsafe (Medicines Safety Authority)

Veiklioji medžiaga:

Cefepime dihydrochloride monohydrate 575.9mg equivalent to 500 mg cefepime free base;  

Prieinama:

Viatris Limited

INN (Tarptautinis Pavadinimas):

Cefepime dihydrochloride monohydrate 575.9 mg (equivalent to 500 mg cefepime free base)

Dozė:

500 mg

Vaisto forma:

Powder for injection

Sudėtis:

Active: Cefepime dihydrochloride monohydrate 575.9mg equivalent to 500 mg cefepime free base   Excipient: Arginine

Vienetai pakuotėje:

Vial, glass, single dose, Type 1 clear glass vial with grey bromo butyl rubber stopper, 500 mg

Klasė:

Prescription

Recepto tipas:

Prescription

Pagaminta:

Aurobindo Pharma Limited

Terapinės indikacijos:

CEFEPIME Mylan is indicated in adults for the treatment of the infections listed below when caused by susceptible bacteria. · Lower respiratory tract infections, including pneumonia and bronchitis. · Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. · Skin and skin structure infections. · Septicaemia. · Intra-abdominal infections, including peritonitis and biliary tract infections. · Empiric treatment of febrile neutropenia.

Produkto santrauka:

Package - Contents - Shelf Life: Vial, glass, single dose, Type 1 clear glass vial with grey bromo butyl rubber stopper - 500 mg - 2 years from date of manufacture stored at or below 25°C protect from light 24 hours reconstituted stored at or below 25°C protect from light 168 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Leidimo data:

2009-06-17